IMGUP22011 // 20321 // Sahasrabudhe
Research Question:
cancer study
Basic Study Information
Purpose:
The aim of this study is to provide darolutamide treatment to patients who participated
in a previous study with darolutamide supported by Bayer and the treating doctor considers
that the continuation of the treatment with darolutamide to be beneficial. Patients
will be carried over from the previous studies and continue in this study with darolutamide
treatment on the same dosage. They will also return to the study centers for doctor's
visits as often as they did in the previous study.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Deepak Sahasrabudhe, MD
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search